Sunshine Guojian Pharmaceutical (Shanghai) Co (SHSE:688336) EV-to-EBIT : 46.74 (As of May. 22, 2025)

Sunshine Guojian Pharmaceutical (Shanghai) Co EV-to-EBIT Chart

Sunshine Guojian Pharmaceutical (Shanghai) Co Annual Data
	Trend	Dec12	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23	Dec24
EV-to-EBIT		Get a 7-Day Free Trial					-57.35	-123.62	178.38	39.67	16.73

Sunshine Guojian Pharmaceutical (Shanghai) Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
EV-to-EBIT	Get a 7-Day Free Trial															33.20	31.40	31.81	16.73	22.09

Competitive Comparison of Sunshine Guojian Pharmaceutical (Shanghai) Co's EV-to-EBIT

For the Biotechnology subindustry, Sunshine Guojian Pharmaceutical (Shanghai) Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sunshine Guojian Pharmaceutical (Shanghai) Co's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sunshine Guojian Pharmaceutical (Shanghai) Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Sunshine Guojian Pharmaceutical (Shanghai) Co's EV-to-EBIT falls into.

Sunshine Guojian Pharmaceutical (Shanghai) Co EV-to-EBIT Calculation

Sunshine Guojian Pharmaceutical (Shanghai) Co's EV-to-EBIT for today is calculated as:

Sunshine Guojian Pharmaceutical (Shanghai) Co's current Enterprise Value is ¥33,610 Mil.
Sunshine Guojian Pharmaceutical (Shanghai) Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥719 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sunshine Guojian Pharmaceutical (Shanghai) Co  (SHSE:688336) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Sunshine Guojian Pharmaceutical (Shanghai) Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2025 is calculated as:

Sunshine Guojian Pharmaceutical (Shanghai) Co's Enterprise Value for the quarter that ended in Mar. 2025 was ¥15,884 Mil.
Sunshine Guojian Pharmaceutical (Shanghai) Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥719 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sunshine Guojian Pharmaceutical (Shanghai) Co EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Sunshine Guojian Pharmaceutical (Shanghai) Co's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Sunshine Guojian Pharmaceutical (Shanghai) Co Business Description